25.3 C
Accra
Friday, November 20, 2026

President Mahama Commissions Ghana’s First DNA Identification Lab At Noguchi, Opens Vaccine Research Facilities

Must read

Ken Kuranchie
Ken Kuranchiehttps://www.thedailysearchlight.com
Chief Editor of The Daily Searchlight Newspaper.
- Advertisement -
- Advertisement -

Ghana can now conduct its own DNA identification tests after President John Mahama commissioned a national human identification laboratory on Wednesday at the University of Ghana’s Noguchi Memorial Institute for Medical Research. He also opened new mRNA and protein laboratories for vaccine research, set up by the National Vaccine Institute and Noguchi as national facilities open to Ghanaian scientists wherever they work. President Mahama said the DNA lab was prompted by the military helicopter crash of 6 August 2025, when tissue recovered from the crash site had to be sent to South Africa for analysis, leaving families waiting several nerve-wracking days for results. “It actually was a day of shame for Ghana that we couldn’t carry out our DNA analysis in country,” President Mahama said. “That will be a thing of the past.”

www.ghanareaders.com

President Mahama said the police will use the laboratory in forensic work, noting that DNA evidence has helped forces elsewhere solve rape and murder cases. It will also settle paternity disputes, he said, which could help families determine rightful inheritance and verify whether children travelling abroad with an adult are truly that adult’s own. “Behind every request for identification is a family that is waiting anxiously for news,” he said, urging agencies using the lab to give families clear information quickly. On vaccines, President Mahama named Atlantic Life Sciences and DEK Laboratories as the two Ghanaian companies selected to develop vaccines, following a meeting of African leaders in Accra on vaccine self-sufficiency. He noted that Ghana is one of only five African countries now working with mRNA technology to research and develop vaccines, thanking Africa CDC for its support, and added that the National Vaccine Institute is in talks with a European partner about using the new lab’s mRNA technology for cancer vaccine research.

Five Ghanaian scientists from Noguchi, WACCBIP, KCCR in Kumasi and the University of Health and Allied Sciences, who trained in Brussels and Accra, will now train colleagues to use the mRNA laboratory. President Mahama urged Ghanaians not to fear clinical trials, recalling an Ebola vaccine trial planned in the Volta Region by researchers including the late Prof Fred Binka, which was moved out of Ghana after a public scare. “Nobody would do the clinical trials for us to develop vaccines in our country,” he said. President Mahama said government has set aside $1 billion for pharmaceuticals under the seventh pillar of its new economy plan to build pharmaceutical and bio-manufacturing hubs, and will spend $46 million this year buying vaccines for child immunisation as Ghana prepares for the end of Gavi support by January 2030.

- Advertisement -

More articles

Latest article